<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01389791</url>
  </required_header>
  <id_info>
    <org_study_id>Mg priming</org_study_id>
    <nct_id>NCT01389791</nct_id>
  </id_info>
  <brief_title>MgSO4 Combined With Rocuronium Priming</brief_title>
  <official_title>MgSO4 Combined With Rocuronium Priming</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Priming with either rocuronium or MgSO4 is known to accelerate the effect of rocuronium on
      muscle relaxation. The purpose of this study is to define the effect of MgSO4 on the
      rocuronium-priming.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acceleration of muscle relaxation is beneficial in rapid-sequence intubation. If MgSO4
      combined with priming is efficient in accelerating muscle relaxation, it would be an
      interesting alternative to rapid-sequence intubation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">January 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time from injection of induction dose of rocuronium until 95% depression of TOF</measure>
    <time_frame>time from injection of induction dose of rocuronium until 95% depression of TOF, upto 5 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>rocuronium duration</measure>
    <time_frame>time from injection of induction dose of rocuronium until train-of-four count reaches two.</time_frame>
    <description>time from injection of induction dose of rocuronium until train-of-four count reaches two.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intubating condition</measure>
    <time_frame>time from injection of induction dose of rocuronium until tracheal intubation.</time_frame>
    <description>rapid sesequence intubation condition is evaluated.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Muscle Relaxation</condition>
  <arm_group>
    <arm_group_label>Roc</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group receive neither MgSO4 nor priming dose of rocuronium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>priming</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in this group receive 0.06mg/kg of rocuronium before 0.54mg/kg of rocuronium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mg&amp;priming</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group receive MgSO4 50mg/kg and 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MgSO4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group receive intravenous MgSO4 before administration of rocuronium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>magnesium sulfate</intervention_name>
    <description>Patients in this group receive intravenous MgSO4 50mg/kg before administration of rocuronium (induction dose).</description>
    <arm_group_label>MgSO4</arm_group_label>
    <other_name>MgSO4</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>priming</intervention_name>
    <description>Patients in this group receive 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium.</description>
    <arm_group_label>priming</arm_group_label>
    <other_name>rocuronium-priming</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>magnesium sulfate and priming</intervention_name>
    <description>Patients in this group receive MgSO4 50mg/kg and 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium.</description>
    <arm_group_label>Mg&amp;priming</arm_group_label>
    <other_name>MgSO4 &amp; priming</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients of ASA Ⅰ-Ⅱ

          -  aged 18~65

          -  scheduled to undergo elective surgery under general anesthesia

        Exclusion Criteria:

          -  risk of pulmonary aspiration

          -  anticipated airway difficulty

          -  reactive airway disease

          -  allergic to study drugs

          -  neuromuscular / cardiovascular/ renal/ hepatic disease

          -  atrioventricular conduction disturbance

          -  BMI &lt; 18.5 or &gt; 24.9

          -  chronic treatment with calcium channel blocker

          -  medications which affect muscle relaxation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanghwan Do, M.D., PH.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mihyun Kim, MD</last_name>
    <phone>82-31-787-2034</phone>
    <email>snmd56@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul national university Bundang hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Kyoung-ki-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2011</study_first_submitted>
  <study_first_submitted_qc>July 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2011</study_first_posted>
  <last_update_submitted>January 6, 2012</last_update_submitted>
  <last_update_submitted_qc>January 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Kim Mihyun</investigator_full_name>
    <investigator_title>full instructor</investigator_title>
  </responsible_party>
  <keyword>muscle relaxation</keyword>
  <keyword>magnesium sulfate</keyword>
  <keyword>rocuronium</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

